Delivery Order SPE2DB22D9367-SPE2DB24FSV08
Award Date
11/20/23
Potential Completion Date
12/12/23
Potential Value
$53K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to supply 3,750 units of ASPARLAS 3,750 UNIT/5 ML VIAL 5ML pharmaceutical products. The delivery order, valued at one hundred five thousand one hundred ninety-nine dollars and twenty cents ($105,199.20), has a completion date of December 27, 2023. No set-aside designation was used for this award. DMS Pharmaceutical Group Inc. will fulfill the...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The order is for 3,750 units of the pharmaceutical product ASPARLAS (5 ml vials) with a potential value of $124,714.50 and a completion date of January 30, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a range of brand-name and generic prescription and over-the-counter drug supplies to the federal...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at two thousand three hundred fifty four dollars and sixty cents ($2,354.60) by the Defense Logistics Agency. This order was issued against the company's indefinite delivery contract to supply pharmaceutical items and medical products to the Defense Logistics Agency through December 2025. Under this particular order, DMS Pharmaceutical Group will provide one hundred fifty milligram vials of fosaprepitant to...
The U.S. Defense Logistics Agency awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 3,750 units of the pharmaceutical product ASPARLAS in 5 mL vials. The contract has a potential value of $55,229.58 and a completion date of March 13, 2024. This delivery order is placed under DMS Pharmaceutical Group's existing indefinite delivery contract with DLA valued at up to $4,999,999, which enables the agency to order a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract has a ceiling value of $138,073.90 and an ultimate completion date of May 29, 2024. DMS Pharmaceutical Group will provide 3,750 units of the pharmaceutical product ASPARLAS (5 ML vial) to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at four thousand eight hundred one dollars and thirty-five cents ($4,801.35) by the Defense Logistics Agency Troop Support Medical. This order was issued against an existing indefinite delivery contract held by DMS Pharmaceutical Group to provide pharmaceuticals and medical supplies with a potential value of up to five million dollars through December 2025. Under this delivery order, DMS Pharmaceutical...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at six thousand four hundred one dollars and eighty cents ($6,401.80) by the Defense Logistics Agency Troop Support Medical. This delivery order was issued against an existing indefinite delivery contract held by DMS Pharmaceutical Group to supply pharmaceutical items and medical products to military treatment facilities supported by the Defense Logistics Agency. Under this delivery order, DMS...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at six thousand four hundred one dollars and eighty cents ($6,401.80) by the Defense Logistics Agency Troop Support Medical. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract to provide pharmaceutical items and medical supplies with a potential value of up to five million dollars through December 2025. Under this order, DMS Pharmaceutical Group will deliver Vabysmo...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical pharmaceutical prime vendor contract for $18,318.75. The order is for pharmaceutical products to support military treatment facilities and will be completed by December 6, 2023. DMS Pharmaceutical Group will provide items such as flumazenil injection, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, selenium...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at twenty-three thousand five hundred thirty-three dollars and sixty-four cents ($23,533.64) by the Defense Logistics Agency. The delivery order is being issued against an existing indefinite delivery contract held by DMS Pharmaceutical Group to supply pharmaceutical items and medical products to military treatment facilities supported by the Defense Logistics Agency. Under this particular delivery order, DMS...